Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients

25Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

From July 2007 to June 2009, all pneumococci causing invasive pneumococcal disease in our hospital were serotyped. Antimicrobial susceptibility was determined by microdilution. Molecular typing was performed by pulsed-field gel electrophoresis and by multilocus sequence typing. Among 251 invasive pneumococci, serotype 8 was the most frequent (13.5%). All serotype 8 strains were susceptible to penicillin; however, 61.8% (21/34) were co-resistant to erythromycin, levofloxacin and tetracycline and identical to the Sweden15A-ST63 clone. Serotype 8 was significantly more frequent among human immunodeficiency virus (HIV)-infected patients (36.5%). The high prevalence of this non-conjugate vaccine multiresistant serotype 8 is a cause for concern mainly in HIV-infected patients. © 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Sanz, J. C., Cercenado, E., Marín, M., Ramos, B., Ardanuy, C., Rodríguez-Avial, I., & Bouza, E. (2011). Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clinical Microbiology and Infection, 17(7), 1094–1098. https://doi.org/10.1111/j.1469-0691.2011.03495.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free